Rituximab regimen helped to maintain remission of ANCA-associated vasculitis

Fixed-interval, repeat-dose rituximab is an effective maintenance therapy for patients with ANCA-associated vasculitis, a retrospective study reports.

The study helps to inform the ideal duration of...